21 August 2009
Pfizer is entering into a collaboration with Private Access, a company specialising in privacy-enhanced search technology, to build a new online community where patients can find out about clinical trials of new drugs and where doctors, companies and researchers can search for test subjects.
"Many patients who could benefit from participation in clinical trials don't enrol in them because they are not aware that potentially relevant research is unde way or they cannot find a specific trial to meet their needs; other woprry that they will lose control of their health information," commented Freda Lewis-Hall, Pfizer's chief medical officer in a press release.
"With unprecedented collaboration among key groups, Pfizer and Private Access believe we can build the preeminent online clinical trial community to be used industry-wide to share knowledge while giving patients the confidence and control to share their health information."
The key to Private Access' technology is that allows patients to control to whom and what purpose they consent access to all, or selected areas, of their personal health information.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.